105785-70-4

Basic information

• Product Name: Benzenamine, 3-[(1-methyl-1H-benzimidazol-2-yl)methoxy]-
• CAS NO: 105785-70-4
• Molecular Formula: C15H15N3O
• Molecular Weight: 253.304
• Mol File: 105785-70-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzenamine, 3-[(1-methyl-1H-benzimidazol-2-yl)methoxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 3-[(1-methyl-1H-benzimidazol-2-yl)methoxy]-(105785-70-4)
• EPA Substance Registry System: Benzenamine, 3-[(1-methyl-1H-benzimidazol-2-yl)methoxy]-(105785-70-4)

Safety Data

• Hazardous Substances Data: 105785-70-4(Hazardous Substances Data)

Upstream product

• 4760-34-3 N-methyl-1,2-phenylenediamine 
• 554-84-7 meta-nitrophenol 
• 4760-35-4 2-chloromethyl-1-methyl-1H-benzimidazole 
• 105785-69-1 3-[(1-methyl-2-benzimidazolyl)methoxy]nitrobenzene 

Downstream Products

• 112230-10-1 Propane-1-sulfonic acid [3-(1-methyl-1H-benzoimidazol-2-ylmethoxy)-phenyl]-amide 
• 103089-77-6 N-Ethyl-3-[(1-methyl-2-benzimidazolyl)methoxy]phenyl sulfonamide 
• 105785-63-5 N-[3-(1-Methyl-1H-benzoimidazol-2-ylmethoxy)-phenyl]-succinamic acid 
• 104256-99-7 4-[[3-[(1-methyl-2-benzimidazolyl)methoxy]phenyl]amino]-4-oxobutanoic acid, methyl ester 
• 112230-09-8 Ethanesulfonic acid [3-(1-methyl-1H-benzoimidazol-2-ylmethoxy)-phenyl]-amide 
• 104257-01-4 3-[[3-[(1-methyl-2-benzimidazolyl)methoxy]phenyl]amino]-3-oxopropanoic acid, methyl ester 
• 112230-11-2 Butane-1-sulfonic acid [3-(1-methyl-1H-benzoimidazol-2-ylmethoxy)-phenyl]-amide 

Relevant articles and documents

Quinoline compounds as antiallergic and antiinflammatory agents

There are disclosed compounds of the formula STR1 wherein R1 is STR2 n is 0-5; R2 is hydrogen, loweralkyl, loweralkoxy, lower alkoxycarbonyl, trifluoromethyl, nitro, cyano or halo; R3 is hydrogen or loweralkyl; R4 hydrogen, lower alkyl, --COOR3 or STR3 R5 is lower alkyl, monofluoroloweralkyl, difluoroloweralkyl, polyfluoroloweralkyl, perfluoroloweralkyl or STR4 and the pharmaceutically acceptable salts thereof, and their use in the treatment of leukotriene-mediated naso-bronchial obstructive airpassageway conditions, such as allergic rhinitis, allergic bronchial asthma and the like, and as antiinflammatory agents.

2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents

There are disclosed compounds of the formula STR1 wherein STR2 R2 is hydrogen, loweralkyl, loweralkoxy, lower alkoxycarbonyl, trifluoromethyl, nitro, cyano or halo; R3 is hydrogen or loweralkyl; R4 is hydrogen, lower alkyl, --COOR3 or STR3 R5 is lower alkyl, monofluoroloweralkyl, difluoroloweralkyl, polyfluoroloweralkyl, perfluoroloweralkyl or STR4 and the pharmaceutically acceptable salts thereof, and their use in the treatment of leukotriene-mediated naso-bronchial obstructive airpassageway conditions, such as allergic rhinitis, allergic bronchial asthma and the like, and as antiinflammatory agents.